Interventional structural cardiologists at Tampa General Hospital (TGH) and USF Health have completed the first procedure in Florida under the FDA Early Feasibility Study pathway for the TricValve® System. The procedure took place in April 2025 on a patient with severe Tricuspid Regurgitation (TR), a life-threatening cardiac condition.
This is part of the TRICAV 1 clinical study led by the Internal Medicine clinical research team at the University of South Florida to evaluate the use of the medical device for potential broader use on patients.
